key: cord-0972049-yg02v2ha
authors: Chan, Hung-Pin; Shen, Daniel Hueng-Yuan; Yang, Ming-Hui; Hu, Chin; Tyan, Yu-Chang
title: Incidental Finding of Moderna COVID-19 Vaccination–Related Axillary Lymphadenopathy on (201)Tl Myocardial Perfusion Imaging
date: 2022-01-12
journal: Clin Nucl Med
DOI: 10.1097/rlu.0000000000003993
sha: 5ea9a0de343086405182833ac060306c788f7374
doc_id: 972049
cord_uid: yg02v2ha

We presented here a 71-year-old man with a history of thyroid cancer post total thyroidectomy and (131)I ablation and right renal cell carcinoma post right partial nephrectomy. He reported persistent chest tightness and pain after the first dose of the Moderna COVID-19 (mRNA-1273) vaccine. Thus, coronary heart disease was suspected, and the patient was referred for MPI (myocardial perfusion imaging). Focal (201)Tl uptake in the left axillary region was found incidentally on MPI, and SPECT/CT revealed enlarged benign-looking lymph nodes. The diagnostic is in favor of reactive hyperplasia after the intramuscular injection of vaccine into left deltoid muscle.

A 71-year-old man with known thyroid cancer status post total thyroidectomy and 131 I ablation in 2012 and right renal cell carcinoma status post right partial nephrectomy in January 2018 under posttreatment follow-up was presented. He also has hypertension and hyperlipidemia on treatment. He felt persistent chest tightness and chest pain after the first dose of the Moderna COVID-19 (mRNA-1273) vaccine. He was referred for a myocardial perfusion imaging (MPI) examination due to suspicious coronary heart disease. MPI results showed unlikely myocardial ischemia. However, 201 Tl-avid focal uptake was found incidentally over the left axillary region on MPI SPECT (A, black arrowhead) and MIP images (B, black arrow). Because of his previous cancer history, SPECT/CT was arranged, which revealed a cluster of lymph nodes in the left axilla (C, transaxial slice, white arrowhead; D, transaxial slice, white arrows), the largest one is 1.5 cm in diameter. Because the patient received a Moderna COVID-19 vaccine in the left upper arm 6 days ago, reactive axillary nodes ipsilateral to the intramuscular injection site are more favored than lymph node metastasis. COVID-19, caused by SARS-CoV-2 infection, is a global pandemic. The course of the disease could range from asymptomatic to death. Moderna, using mRNA biotechnology, is one of COVID-19 vaccines with Emergency Use Authorization. According to SNMMI statement, reactive lymphadenopathy has been reported approximately 16% of the patients who received COVID-19 mRNA vaccines. 1 Previous reports have showed that axillary lymphadenopathy was found on FDG PET/CT after various vaccines injection. [2] [3] [4] [5] Lymph nodes are mostly affected in an intramuscular site of ipsilateral deltoid vaccination seen on FDG PET/CT; however, contralateral lymph nodes may also show FDG uptake. 6 Instead of FDG and 201 Tl, COVID-19 vaccines can lead mild accumulation of some other tracers that was issued in published articles. [7] [8] [9] Nevertheless, it is sometimes limited and confused for evaluating between malignancy and inflammatory disease in breast cancer, lymphoma, or melanoma. 10 By this case, we report a very rare imaging on 201 Tl MPI of incidental finding axillary lymphadenopathy after 6 days of COVID-19 vaccination. With the increasing rate of COVID-19 vaccination in present day, 11 a careful review of the clinical record and raw data of imaging is necessary for interpretation of axillary lymphadenopathy, especially in patients with cancer history.

The Effect of COVID-19 Vaccination on FDG PET/CT. SNMMI Statement. 2021. Available at

COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET/CT

COVID-19 vaccination-associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [ 18 F]Choline PET/CT-not only an FDG finding

Reactive axillary lymphadenopathy to COVID-19 vaccination on 18 F-FDG PET/CT

Effects of COVID-19 vaccination on FDG-PET/CT imaging: a literature review

DOTATATE uptake in an axillary lymph node after COVID-19 vaccination

18 F-Fluciclovine-avid reactive axillary lymph nodes after COVID-19 vaccination

Supraclavicular and axillary lymphadenopathy induced by COVID-19 vaccination on 18 F-fluorthanatrace, 68 Ga-DOTATATE, and 18 F-fluciclovine PET/CT

COVID-19 vaccinationrelated uptake on FDG PET/CT: an emerging dilemma and suggestions for management

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine